Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H34O5 |
Molecular Weight | 378.5024 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C(=O)CC[C@]13CC[C@@H](C)[C@@]2(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]3C)OC(=O)CO
InChI
InChIKey=ZRZNJUXESFHSIO-BKUNHTPHSA-N
InChI=1S/C22H34O5/c1-6-20(4)11-16(27-17(25)12-23)21(5)13(2)7-9-22(14(3)19(20)26)10-8-15(24)18(21)22/h6,13-14,16,18-19,23,26H,1,7-12H2,2-5H3/t13-,14+,16-,18+,19+,20-,21+,22+/m1/s1
Molecular Formula | C22H34O5 |
Molecular Weight | 378.5024 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/16589015Curator's Comment: Description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/22191527;
Sources: http://www.ncbi.nlm.nih.gov/pubmed/16589015
Curator's Comment: Description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/22191527;
Pleuromulin (pleuromulitin) is a natural antibiotic isolated from Basidiomycete Pleurotus. Pleuromulitin exhibits activity mainly against gram-positive bacteria including S. aureus, Klebasiella pneumoniae and Bacillus Subtilis. Pleuromulin is an organic compound which is not reported to be used in as a drug however its derivatives have been used in treatment of infections. The first pleuromulitin that was approved in 1979 for use in veterinary medicine was semi-synthetic derivative tiamulin. Semisynthetic pleuromutilin retapamulin (ALTABAX, GlaxoSmithKline) was the first approved for topical use in humans in 2007. Another derivative of pleuromulin, Lefamulin has been successfully tested in phase 1 clinical trial for systemic use in patients (Nabriva Therapeutics AG).
Originator
Sources: http://www.ncbi.nlm.nih.gov/pubmed/16589015
Curator's Comment: Pleuromutilins were discovered as natural-product antibiotics in 1950.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/16589015
Curator's Comment: Treatment of infected with Streptococcus hemoliticus mice
as a single dose (at 50 mg./kg) or as three doses per day (25 mg/kg or
50 mg/kg) for as long as the mice survived
Route of Administration:
Other
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/16589015
At 0.25 - 2 ug/ml pleuromulin was bacteriostatic for S. aureus, at 4 ug/ml was bacterisidal
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:59:59 GMT 2023
by
admin
on
Sat Dec 16 16:59:59 GMT 2023
|
Record UNII |
3DE4A80MZ1
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
125-65-5
Created by
admin on Sat Dec 16 17:00:01 GMT 2023 , Edited by admin on Sat Dec 16 17:00:01 GMT 2023
|
PRIMARY | |||
|
100000081913
Created by
admin on Sat Dec 16 17:00:01 GMT 2023 , Edited by admin on Sat Dec 16 17:00:01 GMT 2023
|
PRIMARY | |||
|
3933
Created by
admin on Sat Dec 16 17:00:01 GMT 2023 , Edited by admin on Sat Dec 16 17:00:01 GMT 2023
|
PRIMARY | |||
|
C166672
Created by
admin on Sat Dec 16 17:00:01 GMT 2023 , Edited by admin on Sat Dec 16 17:00:01 GMT 2023
|
PRIMARY | |||
|
m8920
Created by
admin on Sat Dec 16 17:00:01 GMT 2023 , Edited by admin on Sat Dec 16 17:00:01 GMT 2023
|
PRIMARY | Merck Index | ||
|
PLEUROMUTILIN
Created by
admin on Sat Dec 16 17:00:01 GMT 2023 , Edited by admin on Sat Dec 16 17:00:01 GMT 2023
|
PRIMARY | |||
|
204-747-5
Created by
admin on Sat Dec 16 17:00:01 GMT 2023 , Edited by admin on Sat Dec 16 17:00:01 GMT 2023
|
PRIMARY | |||
|
121145
Created by
admin on Sat Dec 16 17:00:01 GMT 2023 , Edited by admin on Sat Dec 16 17:00:01 GMT 2023
|
PRIMARY | |||
|
9886081
Created by
admin on Sat Dec 16 17:00:01 GMT 2023 , Edited by admin on Sat Dec 16 17:00:01 GMT 2023
|
PRIMARY | |||
|
3DE4A80MZ1
Created by
admin on Sat Dec 16 17:00:01 GMT 2023 , Edited by admin on Sat Dec 16 17:00:01 GMT 2023
|
PRIMARY | |||
|
SUB09958MIG
Created by
admin on Sat Dec 16 17:00:01 GMT 2023 , Edited by admin on Sat Dec 16 17:00:01 GMT 2023
|
PRIMARY | |||
|
DTXSID9048720
Created by
admin on Sat Dec 16 17:00:01 GMT 2023 , Edited by admin on Sat Dec 16 17:00:01 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105226
Created by
admin on Sat Dec 16 17:00:01 GMT 2023 , Edited by admin on Sat Dec 16 17:00:01 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|